Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Consolidation Therapy With Bortezomib in Patients With Multiple Myeloma Aged 61 to 75

Authors not listed

Janssen-Cilag G.m.b.H · 2006

Abstract

The purpose of this study is to evaluate the efficacy and safety of a consolidation therapy with bortezomib in patients with multiple myeloma aged 61 to 75.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-19 MST

Cite this

APA
Anonymous. (2006). Consolidation Therapy With Bortezomib in Patients With Multiple Myeloma Aged 61 to 75. <em>Janssen-Cilag G.m.b.H</em>. https://clinicaltrials.gov/study/NCT00416208
Vancouver
Anonymous. Consolidation Therapy With Bortezomib in Patients With Multiple Myeloma Aged 61 to 75. Janssen-Cilag G.m.b.H. 2006.
BibTeX
@misc{anon2006Consol, title = {Consolidation Therapy With Bortezomib in Patients With Multiple Myeloma Aged 61 to 75}, author = {Anonymous}, journal = {Janssen-Cilag G.m.b.H}, year = {2006}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings